Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Results
[at noodls] – Record Quarterly Revenue and Earnings Driven by New Product Launches Company Achieves Revised Fiscal Year 2012 Guidance SCHAUMBURG, Ill., Feb. 14, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. … more
View todays social media effects on SGNT
View the latest stocks trending across Twitter. Click to view dashboard